Mediterranean diet plus olive oil may reduce breast cancer risk

By REUTERS
September 14, 2015 23:06

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For a symbolic $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Don't show it again

Over time, eating a Mediterranean-style diet that emphasizes fish, vegetables and particularly olive oil, may lower women's risk of breast cancer compared to following a low-fat diet, suggests a new study from Spain.

In the five-year trial that randomly assigned women to different kinds of diets, those instructed to eat a Mediterranean-style diet with four tablespoons of extra virgin olive oil per day had about half as many breast cancer diagnoses as those on a low-fat diet.

"With an overall healthy diet plus extra virgin olive oil there is a reduction in the hard endpoint of breast cancer," said senior author Dr. Miguel A. Martinez-Gonzalez of the University of Navarra in Pamplona and CIBEROBN in Madrid.

"We have now evidence to support that olive oil is causally related to reduction in risk of breast cancer," he said.

The fact that the findings are based on a randomized trial, the gold-standard of research, "immediately impressed" the journal editors, writes Dr. Mitchell H. Katz, deputy editor of JAMA Internal Medicine, in an editor's note accompanying the study.


Related Content

Breaking news
June 25, 2018
Former bin Laden bodyguard detained in Germany

By REUTERS